Results 211 to 220 of about 96,115 (285)
Developing a model to predict the early risk of hypertriglyceridemia based on inhibiting lipoprotein lipase (LPL): a translational study. [PDF]
Hernandez-Baixauli J +11 more
europepmc +1 more source
Background Diabetes mellitus (DM) is one of the most widespread metabolic diseases characterized by increased blood glucose levels. According to the most recent research, the treatment of diabetes could be improved with the use of green‐synthesized nanoparticles due to their biocompatibility, efficient cellular uptake, and targeted therapy.
Nourhane A. Darwich +5 more
wiley +1 more source
Clinical Significance of Lipoprotein Lipase (LPL) in People Living with HIV: A Comprehensive Assessment Including Lipidemia, Body Composition, Insulin Secretion, and Insulin Resistance. [PDF]
Matsumoto A +10 more
europepmc +1 more source
The breast cancer microenvironment and lipoprotein lipase: Another negative notch for a beneficial enzyme? [PDF]
Bavis MM +4 more
europepmc +1 more source
Background The association between the atherogenic index of plasma (AIP) and different cardiovascular disease (CVD) outcomes remains insufficiently studied. Methods Data from 16,302 US adults in NHANES 2005–2020 were analyzed. CVD outcomes included congestive heart failure, coronary heart disease, angina, heart attack, and stroke.
Yuelin Hu +5 more
wiley +1 more source
Chronic heat stress facilitates lipoprotein lipase expression and triglyceride biosynthesis in the adipose tissue of growing broiler chickens. [PDF]
Tokutake Y +5 more
europepmc +1 more source
Dissociation of stimulatory effects of cortocotrophin on adrenal corticosterone and protein synthesis following hypophysectomy [PDF]
Kluge, F., Scriba, Peter Christian
core
Hyperlipidemia remains a leading modifiable risk factor for cardiovascular morbidity and mortality. Statins are considered the cornerstone of treatment; however, their adverse effects and limited efficacy in certain patient populations necessitate exploration of novel therapeutic avenues. Epiafzelechin (EZN), a flavanol with established antioxidant and
Saud O. Alshammari +8 more
wiley +1 more source

